Esperion Therapeutics (NASDAQ: ESPR) today announced it has entered into a license and distribution agreement with CSL Seqirus (ASX:CSL) for the exclusive rights to commercialize NEXLETOL ® (bempedoic ...

Both the Finnish and the U.S. bird flu vaccines are made by CSL Seqirus but are different vaccines. In the summer, U.S.

As one of the world's largest manufacturers of influenza vaccines, CSL Seqirus is on the front lines in the fight against avian influenza. In fact, the federal government's Biomedical Advanced ...

CSL Seqirus has agreed to provide 665,000 doses of a bird flu vaccine to the European Commission as part of the EU’s efforts to prepare for a potential outbreak of the disease, with an option to ...

Following similar deals in countries like the United States and the U.K., Canada is bolstering its stockpile of bird flu ...

Revenue from CSL's flu vaccine-making business dropped sharply in the first half of the financial year amid a significant fall in immunisation rates, particularly in the US. CSL Seqirus brought in ...

The contract covers more than 5 million doses of a CSL Seqirus H5 influenza shot, according to a government statement, which said the vaccines would be manufactured by the company's UK subsidiary.

Canada has bought half a million vaccines designed to prevent H5N1 avian influenza in humans. The vaccines are intended to stamp out any potential human transmission of the disease by immunising those ...

If newly appointed US health secretary and anti-vaxxer Robert F Kennedy Junior really wants vaccination rates to fall, he won ...

In other avian flu developments, tests at the US Department of Agriculture (USDA) have confirmed the H5N1 strain in rats for ...